Log In
Print this Print this

Anyara, naptumomab estafenatox (ABR-217620)

Also known as: TTS CD3

  Manage Alerts
Collapse Summary General Information
Company Active Biotech AB
Description5T4 antibody combined with a mutated staphylococcal enterotoxin A (SEA)
Molecular Target Oncofetal antigen 5T4
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced cancer
Regulatory Designation
PartnerNeoTX Therapeutics Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today